Astellas launches $3.5 billion hostile bid for OSI
01 March 2010
Simon Varcoe
Astellas has launched a tender offer to acquire OSI Pharmaceuticals, despite the cancer, obesity and diabetes-focused company having previously turned down discussion requests.
Astellas will begin a tender offer on March 2nd to acquire all of OSI's outstanding common stock for $52...
Please Login to read the full article.
01 March 2010
Simon Varcoe
Astellas will begin a tender offer on March 2nd to acquire all of OSI's outstanding common stock for $52...
Please Login to read the full article.
RELATED CONTENT
NEWS
- New funds back Axelar's IGF-1 receptor inhibitor in NSCLC
- CHMP extensions for Roche's Tarceva, Novartis' Afinitor and Wyeth's Enbrel
- Tragara sees peachy Capoxigem future even as APRiCOT trial fails overall in NSCLC
- Mirabegron approved in first market as Gardasil and Rotarix also get formal Japanese nod
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
